Academic pharmacist Nataly Martini highlights the importance of understanding non-Hodgkin lymphoma and pharmacists’ roles in managing this condition
Ten reasons why DHBs need to act to control prescription pricing
+Print Archive
In print
NEWS
Ten reasons why DHBs need to act to control prescription pricing
Thursday 1 February 2018, 12:00 PM

With Chemist Warehouse bursting onto the scene late last year offering zero prescription fees, prescription pricing has again become a topic of conversation. After working as a pharmacy wholesaler for 10 years, and in health in general for 35 years, pharmacy sector observer Anna Mickell has a few ideas on what works and what doesn’t. She gives her opinion on why prescription prices need to be controlled by DHBs
Despite a few left-leaning tendencies, I support a market approach when it comes to matters of health.
I think the Government and its agents need t